Chemo Pharma Laboratories has informed that a meeting of the board of directors of the company will be held on January 14, 2013, to consider and approve the un-audited financial results for the quarter ended December 31, 2012 and to place and take on record the limited review report on un-audited financial results for the quarter ended December 31, 2012.
Further, the board to consider and approve the appointment of Ashok Somani as additional director of the company and the resignation of M. S. Vyas, as director of the company.
The above information is a part of company’s filings submitted to BSE.
